Funders › NY › International AIDS Vaccine Initiative Inc › 2023
Grants paid by International AIDS Vaccine Initiative Inc, tax year 2023
EIN 13-3870223 · New York, NY · Form 990, Schedule I · NTEE Q300
In tax year 2023, International AIDS Vaccine Initiative Inc (EIN 13-3870223) reported 23 grants paid totaling $9,190,196. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | The Scripps Research Institute - Osp La Jolla, CA | A | $3,088,050 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Texas Biomedical Research Institute San Antonio, TX | A | $1,667,115 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | La Jolla Institute for Allergy & Immunology La Jolla, CA | A | $592,672 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Emory University Atlanta, GA | A | $462,130 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | The University of Texas Medical Branch Galveston Galveston, TX | A | $453,031 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Boston University Boston, MA | A | $432,798 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Lsb Research Group LLC Miles, TX | A | $401,699 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Seattle Children's Hospital Seattle, WA | A | $270,413 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Northwestern University Chicago, IL | A | $250,000 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | 10x Genomics Inc Pleasanton, CA | A | $243,904 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Clinical Trials of Texas LLC San Antonio, CA | A | $194,767 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | The Population Council Inc New York, NY | A | $146,260 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Trustees of Tufts College Aka Tufts University Somerville, MA | A | $140,553 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Tulane University New Orleans, LA | A | $138,082 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | The Brigham and Women's Hopital Inc Boston, MA | A | $128,516 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Fred Hutchinson Cancer Reseach Center Seattle, WA | A | $125,001 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | George Washington University Ashburn, VA | A | $117,381 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | The University of Texas Health Science Center Sa San Antonio, TX | A | $71,900 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Applied Biomedical Science Institute San Diego, CA | A | $70,933 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Path Washington, DC | A | $64,068 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $56,963 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | Nc State Treasurer Raleigh, NC | A | $41,470 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
| 2023 | University of Washington Seattle, WA | A | $32,490 | paid | RESEARCH & DEVELOPMENT | 202412049349300811 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.